These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 21444016)

  • 21. Classification criteria for polymyositis and dermatomyositis.
    Tanimoto K; Nakano K; Kano S; Mori S; Ueki H; Nishitani H; Sato T; Kiuchi T; Ohashi Y
    J Rheumatol; 1995 Apr; 22(4):668-74. PubMed ID: 7791161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases.
    Lorenzoni PJ; Scola RH; Kay CS; Prevedello PG; Espíndola G; Werneck LC
    Pediatr Neurol; 2011 Jul; 45(1):17-22. PubMed ID: 21723454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyositis: not a unicorn or mythological beast...but maybe a duck?
    Kissel JT
    Neurology; 2008 Feb; 70(6):414-5. PubMed ID: 18250286
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of oral manifestations and masticatory force in patients with polymyositis and dermatomyositis.
    Márton K; Hermann P; Dankó K; Fejérdy P; Madléna M; Nagy G
    J Oral Pathol Med; 2005 Mar; 34(3):164-9. PubMed ID: 15689230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misunderstandings, misperceptions, and mistakes in the management of the inflammatory myopathies.
    Kissel JT
    Semin Neurol; 2002 Mar; 22(1):41-51. PubMed ID: 12170392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Classification and Management of Inflammatory Myopathies.
    Schmidt J
    J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):1. PubMed ID: 19336018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ; Amato AA
    Neurol Clin; 2014 Aug; 32(3):595-628, vii. PubMed ID: 25037081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory muscle disease - An update.
    Baig S; Paik JJ
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymyositis: an overdiagnosed entity.
    van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
    Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distal inflammatory myopathy: unusual presentation of polymyositis or new entity?
    Dimitri D; Dubourg O; Maisonobe T; Fournier E; Ranque B; Laforêt P; Mussini JM; Pagnoux C; Béhin A; Papo T; Benveniste O; Eymard B; Herson S
    Neuromuscul Disord; 2008 Jun; 18(6):493-500. PubMed ID: 18534849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic inflammatory myopathies.
    Amato AA; Barohn RJ
    Neurol Clin; 1997 Aug; 15(3):615-48. PubMed ID: 9227956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D
    Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.